Basic Ordering Agreement H9224024G0009

This Basic Ordering Agreement was awarded by the U.S. Special Operations Command (SOCOM), a defense agency, to the University of Chicago, a private research university. The $146.3 million IDV contract supports the evaluation and development of animal and animal replacement models for screening and assessing candidate countermeasures such as therapeutics, vaccines, and diagnostics targeting priority infectious agents, including emerging viruses, antimicrobial resistant pathogens, and neglected tropical diseases.

The contract is divided into four task areas covering small animal models, non-human primate models, animal replacement and non-traditional animal models, and specialized reagent generation and distribution. This IDV enables NIAID to issue task orders to the University of Chicago for specific studies assessing the safety, efficacy, and pharmacology of medical countermeasures. The contract has an ultimate completion date of April 28, 2034 and does not have a set-aside designation, reflecting the University of Chicago's status as a large, established research institution. The university often collaborates with other academic institutions, national laboratories, and industry partners on its federal contract and grant efforts.